The Effects of a Dynamic Arm Support in Daily Life
Condition(s) studied
Investigational drug(s) / intervention(s)
Dynamic arm support: The participant will receive a new dynamic arm support.
Study summary
The goal of this mixed method study is to learn about how a dynamic arm support device (DAS) helps people with everyday activities. The study focuses on people with neuro(-muscular) conditions, age 16 and older. The research questions that are formulated, are:
* How does a person experience their daily activities, with and without a DAS?
* What are the contextual (external and personal) factors that influence the use of a DAS?
Participants will take part in three testing sessions. In each session, they must complete a few questionnaires and participate in an interview. The first time, without DAS. In the second and third session, they will be using their DAS (resp. 3 to 4 weeks and 3 months). The data collection will be executed by phone, digital questionnaires and/or paper.
Eligibility
Primary outcome measure(s)
- Canadian Occupational Performance Measure (COPM) — Test moment 0: Assessment before delivery of dynamic arm support (DAS), Test moment 1: assessment 3 weeks after delivery, Test moment 2: assessment 3 months after delivery
The COPM is a semi-structured interview, where the participants give at least 5 activities of daily life. They give a score of satisfaction and performance (between 1 and 10) on these 5 activities. - Psychosocial impact of assistive devices scale (PIADS) — Test moment 1: assessment 3 weeks after delivery, Test moment 2: assessment 3 months after delivery
The psychosocial impact of assistive devices scale is a 26-item, self-report questionnaire designed to assess the effects of an assistive device (the DAS) on functional independence, well-being, and quality of life. Scores on competence (between -3 and +3), adaptability (between -3 and +3) and self-esteem (between -3 and +3).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Focal Meditech BV (their clients in their home situation) | Tilburg | Netherlands | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07121075 on ClinicalTrials.gov ↗ ← All trials in the Netherlands